CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Blood Glucose Monitoring System Altitude Performancedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02916563
NCT02916563N/ACompleted
CompareCT.gov

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation

LabStyle Innovations Ltd.·interventional·Posted Sep 27, 2016·Updated Nov 19, 2020

In Brief

A clinical study evaluating Blood Glucose Monitoring System Altitude Performance for Diabetes Mellitus. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 27, 2016
Enrollment StartJul 1, 2016
Primary CompletionJul 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 9.8 years ago

Interventions

Blood Glucose Monitoring System Altitude Performancedevice

Performance as assessed against a reference method at an altitude of approximately 10,000 feet.